Prana’s Anti-Parkinsonian compound PBT434 presented at 13th International Conference for Alzheimer’s & Parkinson’s Diseases March 30, 2017
Prana Announces that PBT2 Reduces Cognitive Impairment Caused by Tau Protein Accumulation July 17, 2013
